Tatyana Dyuzheva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tatyana Dyuzheva has a total of 255 co-authors. Here are the top co-authors by number of shared publications:
- Aleksey Lyundup
Research and Education Resource Center for Cellular Technologies, Peoples Friendship University (RUDN University), 117198 Moscow, Russia
9 shared publications - Daniil Mudryak
Moscow Clinical Hospital named after V. V. Veresaev
7 shared publications - Maksim V. Balyasin
Peoples’ Friendship University of Russia
7 shared publications - Ilya Klabukov
National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Koroleva St. 4, 249036 Obninsk, Russia
6 shared publications - Mikhail Krasheninnikov
Research and Education Resource Center for Cellular Technologies, Peoples Friendship University (RUDN University), 117198 Moscow, Russia
5 shared publications Люндуп А. В
Первый Московский государственный медицинский университет им. И.М. Сеченова
5 shared publications
Latest Publications
- Open Access
- 2 July 2026
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 31 (2) , 52-60
Outcomes of pancreatic duct stenting in patients with different types of pancreatic necrosis
Aim. To examine the immediate outcomes of pancreatic duct stenting in cases of pancreatic necrosis and to identify potential factors that may reduce the effectiveness of the procedure. Materials and Methods. A retrospective pilot study was conducted to evaluate the outcomes of endoscopic transpapillary stenting of the pancreatic duct in 77 patients with severe acute pancreatitis. The efficacy of the procedure was assessed by monitoring the dynamics of peripancreatic inflammation, organ dysfunction, infection development, and patient mortality. Results. No complications arose during endoscopic transpapillary procedures. The progression of parapancreatitis was observed in 29 patients following stenting: early organ failure in 18 patients and infection in 19; 6 patients died. A regression in parapancreatitis was observed in 33 patients: 7 had organ failure and 12 had infection (p < 0.05 compared with the previous group); no deaths occurred. In 15 patients, no dynamics of parapancreatitis were observed. The most significant results were obtained in 25 patients with Type I pancreatic necrosis. In 11 of these patients, the distal segment of the 87.3 ± 6.7 mm stent was located in the duct of viable parenchyma beyond the necrosis zone. A regression in parapancreatitis was observed, dropping from an average of 5.45 ± 0.92 points to 2.90 ± 0.47 points (p < 0.023). No cases of early organ dysfunction or fatalities occurred. In 14 patients, the distal segment of the stent (65/0 ± 4.9 mm in length; p < 0.05) remained in the duct within the necrotic zone. Parapancreatitis did not improve (4.93 ± 0.85 vs. 6.36 ± 0.77; p = 0.22), five patients developed organ failure (p = 0.0267), and three patients died. Conclusion. The role of parapancreatitis progression in the development of early organ failure has been established. The feasibility, efficacy, and safety of recanalization of the pancreatic duct through an area of Type I pancreatic necrosis have been demonstrated. The CT scan results must be available before the endoscopic procedure. A sufficiently long stent must be used to drain the duct beyond the necrotic area and into the viable glandular parenchyma. It is not advisable to stent the duct without reaching viable parenchyma, as this does not lead to resolution of parapancreatitis or improved treatment outcomes.
- 2 July 2026
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 31 (2) , 52-60
Open AccessOutcomes of pancreatic duct stenting in patients with different types of pancreatic necrosis
Aim. To examine the immediate outcomes of pancreatic duct stenting in cases of pancreatic necrosis and to identify potential factors that may reduce the effectiveness of the procedure. Materials and Methods. A retrospective pilot study was conducted to evaluate the outcomes of endoscopic transpapillary stenting of the pancreatic duct in 77 patients with severe acute pancreatitis. The efficacy of the procedure was assessed by monitoring the dynamics of peripancreatic inflammation, organ dysfunction, infection development, and patient mortality. Results. No complications arose during endoscopic transpapillary procedures. The progression of parapancreatitis was observed in 29 patients following stenting: early organ failure in 18 patients and infection in 19; 6 patients died. A regression in parapancreatitis was observed in 33 patients: 7 had organ failure and 12 had infection (p < 0.05 compared with the previous group); no deaths occurred. In 15 patients, no dynamics of parapancreatitis were observed. The most significant results were obtained in 25 patients with Type I pancreatic necrosis. In 11 of these patients, the distal segment of the 87.3 ± 6.7 mm stent was located in the duct of viable parenchyma beyond the necrosis zone. A regression in parapancreatitis was observed, dropping from an average of 5.45 ± 0.92 points to 2.90 ± 0.47 points (p < 0.023). No cases of early organ dysfunction or fatalities occurred. In 14 patients, the distal segment of the stent (65/0 ± 4.9 mm in length; p < 0.05) remained in the duct within the necrotic zone. Parapancreatitis did not improve (4.93 ± 0.85 vs. 6.36 ± 0.77; p = 0.22), five patients developed organ failure (p = 0.0267), and three patients died. Conclusion. The role of parapancreatitis progression in the development of early organ failure has been established. The feasibility, efficacy, and safety of recanalization of the pancreatic duct through an area of Type I pancreatic necrosis have been demonstrated. The CT scan results must be available before the endoscopic procedure. A sufficiently long stent must be used to drain the duct beyond the necrotic area and into the viable glandular parenchyma. It is not advisable to stent the duct without reaching viable parenchyma, as this does not lead to resolution of parapancreatitis or improved treatment outcomes.
- Open Access
- 27 June 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 184 (2) , 27-32
Procalcitonin test as an indicator of the severity of acute biliary pancreatitis
The objective of this study was to investigate the use of the procalcitonin test as a marker for the severity of acute biliary pancreatitis.Methods and materials. A retrospective study was conducted to assess the severity of acute biliary pancreatitis in 45 patients. The severity was determined by the presence and duration of organ failure, the severity of acute cholangitis, and pancreatic necrosis. CT scans were performed in 30 patients and markers of inflammation (procalcitonin, C-reactive protein, and leukocyte levels) were studied. Procalcitonin was assessed by chemiluminescence enzyme immunoassay, and the level above 0.5 ng/ml was considered positive.Results. Organ failure was present in 22 of 45 patients and absent in the remaining 23. Among those with organ failure, 10 patients had severe acute cholangitis, 3 had pancreatic necrosis, and 9 had both acute cholangitis and necrosis. Three patients died. Without organ dysfunction, all 18 from 30 patients had interstitial pancreatitis, with 6 having no acute cholangitis, 10 having mild cholangitis, and 7 having moderate severity. ROC analysis data: area under the curve (AUC) for procalcitonin was 0.788, cut-off point was 0.6 ng/mL, sensitivity and specificity were 79 % and 76 % respectively, p-value was 0.001. For CRP, AUC was 0.524, cut-off point was 40 mg/L, sensitivity was 58 % and specificity was 61 %, p-value was 0.785. Leukocytes had an AUC of 0.594, with a cut-off of 10´109/L, sensitivity was 58 % and specificity was 66 %, p-value was 0.265.Conclusion. The procalcitonin test with a level of 0.6 ng/mL or higher has good diagnostic value in predicting organ failure in acute biliary pancreatitis patients, with greater sensitivity compared to CRP and leukocytes.
- 27 June 2025
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 184 (2) , 27-32
Open AccessProcalcitonin test as an indicator of the severity of acute biliary pancreatitis
The objective of this study was to investigate the use of the procalcitonin test as a marker for the severity of acute biliary pancreatitis.Methods and materials. A retrospective study was conducted to assess the severity of acute biliary pancreatitis in 45 patients. The severity was determined by the presence and duration of organ failure, the severity of acute cholangitis, and pancreatic necrosis. CT scans were performed in 30 patients and markers of inflammation (procalcitonin, C-reactive protein, and leukocyte levels) were studied. Procalcitonin was assessed by chemiluminescence enzyme immunoassay, and the level above 0.5 ng/ml was considered positive.Results. Organ failure was present in 22 of 45 patients and absent in the remaining 23. Among those with organ failure, 10 patients had severe acute cholangitis, 3 had pancreatic necrosis, and 9 had both acute cholangitis and necrosis. Three patients died. Without organ dysfunction, all 18 from 30 patients had interstitial pancreatitis, with 6 having no acute cholangitis, 10 having mild cholangitis, and 7 having moderate severity. ROC analysis data: area under the curve (AUC) for procalcitonin was 0.788, cut-off point was 0.6 ng/mL, sensitivity and specificity were 79 % and 76 % respectively, p-value was 0.001. For CRP, AUC was 0.524, cut-off point was 40 mg/L, sensitivity was 58 % and specificity was 61 %, p-value was 0.785. Leukocytes had an AUC of 0.594, with a cut-off of 10´109/L, sensitivity was 58 % and specificity was 66 %, p-value was 0.265.Conclusion. The procalcitonin test with a level of 0.6 ng/mL or higher has good diagnostic value in predicting organ failure in acute biliary pancreatitis patients, with greater sensitivity compared to CRP and leukocytes.
- Open Access
- 19 December 2024
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 29 (4) , 98-106
Acute biliary pancreatitis: severity criteria, role of biliary sludge, treatment
Aim. To investigate the severity criteria of acute biliary pancreatitis in various causes of bile outflow obstruction into the duodenum, including biliary sludge, and to analyze the treatment outcomes of patients.Materials and methods. A retrospective analysis was conducted on the diagnostic and treatment results of 89 patients with a confirmed cause of obstruction of the common bile duct following endoscopic papillosphincterotomy. The severity of pancreatitis was assessed in terms of organ failure, pancreatic necrosis, and the severity of cholangitis. The presence of sludge in the gallbladder was evaluated by means of ultrasound, and papillitis was assessed during esophagogastroduodenoscopy.Results. In Group 1, 23 patients had biliary sludge as the cause of bile outflow obstruction; in Group 2 (n = 32), the cause lied in an impacted stone; and in Group 3 (n = 34), in choledocholithiasis. Organ failure was noted in 11 patients of group 1, in 13 patients of group 2, and in 7 patients of group 3 (p < 0.04). In group 1, organ failure occurred against the background of pancreatic necrosis (n = 7) and acute cholangitis (n = 4); in group 2, all 13 patients exhibited acute cholangitis (p < 0.05). The proportion of patients with papillitis was significantly higher in Groups 1 and 2. Sludge in the gallbladder was detected in 14 patients of Group 1, 4 patients of Group 2, and 8 patients of Group 3 (p < 0.001). Nasobiliary drainage after endoscopic papillosphincterotomy was applied in 34 cases, pancreatic duct stenting in 33 cases, and invasive interventions for peripancreatitis in 9 cases. 3 patients (3.4%) died.Conclusion. Pancreatic necrosis and acute cholangitis determined the severity of acute biliary pancreatitis, which is consistent with the concept of 2 types of disease – pancreatic and biliary. Biliary sludge in the bile duct, alongside impacted stones, caused bile duct obstruction in patients with organ failure. Sludge in the gallbladder and papillitis, along with signs of biliary hypertension, suggest its presence in the common bile duct and indicates the need for endoscopic papillosphincterotomy. The identified patterns appear relevant and may be considered in protocols for subsequent prospective studies.
- 19 December 2024
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 29 (4) , 98-106
Open AccessAcute biliary pancreatitis: severity criteria, role of biliary sludge, treatment
Aim. To investigate the severity criteria of acute biliary pancreatitis in various causes of bile outflow obstruction into the duodenum, including biliary sludge, and to analyze the treatment outcomes of patients.Materials and methods. A retrospective analysis was conducted on the diagnostic and treatment results of 89 patients with a confirmed cause of obstruction of the common bile duct following endoscopic papillosphincterotomy. The severity of pancreatitis was assessed in terms of organ failure, pancreatic necrosis, and the severity of cholangitis. The presence of sludge in the gallbladder was evaluated by means of ultrasound, and papillitis was assessed during esophagogastroduodenoscopy.Results. In Group 1, 23 patients had biliary sludge as the cause of bile outflow obstruction; in Group 2 (n = 32), the cause lied in an impacted stone; and in Group 3 (n = 34), in choledocholithiasis. Organ failure was noted in 11 patients of group 1, in 13 patients of group 2, and in 7 patients of group 3 (p < 0.04). In group 1, organ failure occurred against the background of pancreatic necrosis (n = 7) and acute cholangitis (n = 4); in group 2, all 13 patients exhibited acute cholangitis (p < 0.05). The proportion of patients with papillitis was significantly higher in Groups 1 and 2. Sludge in the gallbladder was detected in 14 patients of Group 1, 4 patients of Group 2, and 8 patients of Group 3 (p < 0.001). Nasobiliary drainage after endoscopic papillosphincterotomy was applied in 34 cases, pancreatic duct stenting in 33 cases, and invasive interventions for peripancreatitis in 9 cases. 3 patients (3.4%) died.Conclusion. Pancreatic necrosis and acute cholangitis determined the severity of acute biliary pancreatitis, which is consistent with the concept of 2 types of disease – pancreatic and biliary. Biliary sludge in the bile duct, alongside impacted stones, caused bile duct obstruction in patients with organ failure. Sludge in the gallbladder and papillitis, along with signs of biliary hypertension, suggest its presence in the common bile duct and indicates the need for endoscopic papillosphincterotomy. The identified patterns appear relevant and may be considered in protocols for subsequent prospective studies.
- Open Access
- 20 August 2024
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 183 (5) , 41-44
Late hemorrhagic complication of pancreonecrosis
There is a case report of two years medical history from the moment of acute pancreonecrosis to reconstructive operation (pancreatodigestive anastomosis) of the patient 56 years old. We showed the ability to use criteria about the depth and configuration of pancreatic necrosis in acute pancreatitis to prognose late complications. Underestimation of deep parenchymal necrosis in the pancreatic neck and body, high -amylase activity for diagnosis of disconnected pancreatic duct syndrome, unjustified drainage removal in external pancreatic fistula led to pseudocyst formation. Pseudocyst progression, erosion of mesenteric vessel with bleeding into the cyst cavity with its subsequent rupture and intra-abdominal bleeding 1 developed a year after acute pancreatitis. The need to perform intervention was the reason why reconstructive operation was delayed for a long time.
- 20 August 2024
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Grekov's Bulletin of Surgery
- Vol. 183 (5) , 41-44
Open AccessLate hemorrhagic complication of pancreonecrosis
There is a case report of two years medical history from the moment of acute pancreonecrosis to reconstructive operation (pancreatodigestive anastomosis) of the patient 56 years old. We showed the ability to use criteria about the depth and configuration of pancreatic necrosis in acute pancreatitis to prognose late complications. Underestimation of deep parenchymal necrosis in the pancreatic neck and body, high -amylase activity for diagnosis of disconnected pancreatic duct syndrome, unjustified drainage removal in external pancreatic fistula led to pseudocyst formation. Pseudocyst progression, erosion of mesenteric vessel with bleeding into the cyst cavity with its subsequent rupture and intra-abdominal bleeding 1 developed a year after acute pancreatitis. The need to perform intervention was the reason why reconstructive operation was delayed for a long time.
- Open Access
- 14 June 2023
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 28 (2) , 70-78
Effect of pancreatic necrosis configuration on the dynamics of external pancreatic fistulas after acute pancreatitis
Влияние конфигурации некроза поджелудочной железы на течение наружных панкреатических свищей после острого панкреатита
- 14 June 2023
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 28 (2) , 70-78
Open AccessEffect of pancreatic necrosis configuration on the dynamics of external pancreatic fistulas after acute pancreatitis
Влияние конфигурации некроза поджелудочной железы на течение наружных панкреатических свищей после острого панкреатита
- Open Access
- 19 March 2023
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 28 (1) , 53-61
Perfusion CT in predicting deep pancreatic necrosis and planning early interventions for severe acute pancreatitis
Значение перфузионной КТ в прогнозировании глубокого некроза поджелудочной железы и планировании ранних вмешательств при тяжелом остром панкреатите
- 19 March 2023
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 28 (1) , 53-61
Open AccessPerfusion CT in predicting deep pancreatic necrosis and planning early interventions for severe acute pancreatitis
Значение перфузионной КТ в прогнозировании глубокого некроза поджелудочной железы и планировании ранних вмешательств при тяжелом остром панкреатите
- Open Access
- 1 March 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (3) , 745
Biomechanical Behaviors and Degradation Properties of Multilayered Polymer Scaffolds: The Phase Space Method for Bile Duct Design and Bioengineering
This article reports the electrospinning technique for the manufacturing of multilayered scaffolds for bile duct tissue engineering based on an inner layer of polycaprolactone (PCL) and an outer layer either of a copolymer of D,L-lactide and glycolide (PLGA) or a copolymer of L-lactide and ε-caprolactone (PLCL). A study of the degradation properties of separate polymers showed that flat PCL samples exhibited the highest resistance to hydrolysis in comparison with PLGA and PLCL. Irrespective of the liquid-phase nature, no significant mass loss of PCL samples was found in 140 days of incubation. The PLCL- and PLGA-based flat samples were more prone to hydrolysis within the same period of time, which was confirmed by the increased loss of mass and a significant reduction of weight-average molecular mass. The study of the mechanical properties of developed multi-layered tubular scaffolds revealed that their strength in the longitudinal and transverse directions was comparable with the values measured for a decellularized bile duct. The strength of three-layered scaffolds declined significantly because of the active degradation of the outer layer made of PLGA. The strength of scaffolds with the PLCL outer layer deteriorated much less with time, both in the axial (p-value = 0.0016) and radial (p-value = 0.0022) directions. A novel method for assessment of the physiological relevance of synthetic scaffolds was developed and named the phase space approach for assessment of physiological relevance. Two-dimensional phase space (elongation modulus and tensile strength) was used for the assessment and visualization of the physiological relevance of scaffolds for bile duct bioengineering. In conclusion, the design of scaffolds for the creation of physiologically relevant tissue-engineered bile ducts should be based not only on biodegradation properties but also on the biomechanical time-related behavior of various compositions of polymers and copolymers.
- 1 March 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (3) , 745
Open AccessBiomechanical Behaviors and Degradation Properties of Multilayered Polymer Scaffolds: The Phase Space Method for Bile Duct Design and Bioengineering
This article reports the electrospinning technique for the manufacturing of multilayered scaffolds for bile duct tissue engineering based on an inner layer of polycaprolactone (PCL) and an outer layer either of a copolymer of D,L-lactide and glycolide (PLGA) or a copolymer of L-lactide and ε-caprolactone (PLCL). A study of the degradation properties of separate polymers showed that flat PCL samples exhibited the highest resistance to hydrolysis in comparison with PLGA and PLCL. Irrespective of the liquid-phase nature, no significant mass loss of PCL samples was found in 140 days of incubation. The PLCL- and PLGA-based flat samples were more prone to hydrolysis within the same period of time, which was confirmed by the increased loss of mass and a significant reduction of weight-average molecular mass. The study of the mechanical properties of developed multi-layered tubular scaffolds revealed that their strength in the longitudinal and transverse directions was comparable with the values measured for a decellularized bile duct. The strength of three-layered scaffolds declined significantly because of the active degradation of the outer layer made of PLGA. The strength of scaffolds with the PLCL outer layer deteriorated much less with time, both in the axial (p-value = 0.0016) and radial (p-value = 0.0022) directions. A novel method for assessment of the physiological relevance of synthetic scaffolds was developed and named the phase space approach for assessment of physiological relevance. Two-dimensional phase space (elongation modulus and tensile strength) was used for the assessment and visualization of the physiological relevance of scaffolds for bile duct bioengineering. In conclusion, the design of scaffolds for the creation of physiologically relevant tissue-engineered bile ducts should be based not only on biodegradation properties but also on the biomechanical time-related behavior of various compositions of polymers and copolymers.
- Open Access
- 11 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (2) , 1399
Angiogenic Modification of Microfibrous Polycaprolactone by pCMV-VEGF165 Plasmid Promotes Local Vascular Growth after Implantation in Rats
Insufficient vascular growth in the area of artificial-material implantation contributes to ischemia, fibrosis, the development of bacterial infections, and tissue necrosis around the graft. The purpose of this study was to evaluate angiogenesis after implantation of polycaprolactone microfiber scaffolds modified by a pCMV-VEGF165-plasmid in rats. Influence of vascularization on scaffold degradation was also examined. We investigated flat microfibrous scaffolds obtained by electrospinning polycaprolactone with incorporation of the pCMV-VEGF-165 plasmid into the microfibers at concentrations of 0.005 ng of plasmid per 1 mg of polycaprolactone (0.005 ng/mg) (LCGroup) and 0.05 ng/mg (HCGroup). The samples were subcutaneously implanted in the interscapular area of rats. On days 7, 16, 33, 46, and 64, the scaffolds were removed, and a histological study with a morphometric evaluation of the density and diameter of the vessels and microfiber diameter was performed. The number of vessels was increased in all groups, as well as the resorption of the scaffold. On day 33, the vascular density in the HCGroup was 42% higher compared to the control group (p = 0.0344). The dose-dependent effect of the pCMV-VEGF165-plasmid was confirmed by enhanced angiogenesis in the HCGroup compared to the LCGroup on day 33 (p-value = 0.0259). We did not find a statistically significant correlation between scaffold degradation rate and vessel growth (the Pearson correlation coefficient was ρ = 0.20, p-value = 0.6134). Functionalization of polycaprolactone by incorporation of the pCMV-VEGF165 plasmid provided improved vascularization within 33 days after implantation, however, vessel growth did not seem to correlate with scaffold degradation rate.
- 11 January 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (2) , 1399
Open AccessAngiogenic Modification of Microfibrous Polycaprolactone by pCMV-VEGF165 Plasmid Promotes Local Vascular Growth after Implantation in Rats
Insufficient vascular growth in the area of artificial-material implantation contributes to ischemia, fibrosis, the development of bacterial infections, and tissue necrosis around the graft. The purpose of this study was to evaluate angiogenesis after implantation of polycaprolactone microfiber scaffolds modified by a pCMV-VEGF165-plasmid in rats. Influence of vascularization on scaffold degradation was also examined. We investigated flat microfibrous scaffolds obtained by electrospinning polycaprolactone with incorporation of the pCMV-VEGF-165 plasmid into the microfibers at concentrations of 0.005 ng of plasmid per 1 mg of polycaprolactone (0.005 ng/mg) (LCGroup) and 0.05 ng/mg (HCGroup). The samples were subcutaneously implanted in the interscapular area of rats. On days 7, 16, 33, 46, and 64, the scaffolds were removed, and a histological study with a morphometric evaluation of the density and diameter of the vessels and microfiber diameter was performed. The number of vessels was increased in all groups, as well as the resorption of the scaffold. On day 33, the vascular density in the HCGroup was 42% higher compared to the control group (p = 0.0344). The dose-dependent effect of the pCMV-VEGF165-plasmid was confirmed by enhanced angiogenesis in the HCGroup compared to the LCGroup on day 33 (p-value = 0.0259). We did not find a statistically significant correlation between scaffold degradation rate and vessel growth (the Pearson correlation coefficient was ρ = 0.20, p-value = 0.6134). Functionalization of polycaprolactone by incorporation of the pCMV-VEGF165 plasmid provided improved vascularization within 33 days after implantation, however, vessel growth did not seem to correlate with scaffold degradation rate.
- 9 September 2022
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 23 (3) , 619-643
Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies
Diagnosis and treatment of carcinoma of the exocrine part of the pancreas is a serious problem for modern medicine. Despite the identification of a large number of aberrant mutations in pancreatic ductal adenocarcinoma (PDAC), attempts to create effective therapeutic agents based on identified genetic or epigenetic variations have not been succesful. The role of the tumor microenvironment (TME) in tumor progression is currently a popular topic. Cancer-associated fibroblasts (CAFs) and extracellular matrix (ECM) are the main components of the tumor stroma and play an important role in the proliferation, invasiveness and metastasis of cancer. However, the mechanisms underlying the effect of CAFs and ECM on cancer progression are still unclear. Recent studies on stromal components and blockage of signaling pathways have brought some optimism to this area. New information on the role of TME will lead to the development of targeted therapies or combinations with modern chemotherapy for PDAC.
- 9 September 2022
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 23 (3) , 619-643
Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies
Diagnosis and treatment of carcinoma of the exocrine part of the pancreas is a serious problem for modern medicine. Despite the identification of a large number of aberrant mutations in pancreatic ductal adenocarcinoma (PDAC), attempts to create effective therapeutic agents based on identified genetic or epigenetic variations have not been succesful. The role of the tumor microenvironment (TME) in tumor progression is currently a popular topic. Cancer-associated fibroblasts (CAFs) and extracellular matrix (ECM) are the main components of the tumor stroma and play an important role in the proliferation, invasiveness and metastasis of cancer. However, the mechanisms underlying the effect of CAFs and ECM on cancer progression are still unclear. Recent studies on stromal components and blockage of signaling pathways have brought some optimism to this area. New information on the role of TME will lead to the development of targeted therapies or combinations with modern chemotherapy for PDAC.
- Open Access
- 15 May 2022
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 32 (2) , 99-156
Clinical Guidelines of the Russian Society of Surgeons, the Russian Gastroenterological Association, the Association of Surgeons-Hepatologists and the Endoscopic Society “REndO” on Diagnostics and Treatment of Chronic Pancreatitis
Aim:to present modern methods of diagnosis and treatment of chronic pancreatitis for gastroenterologists, general practitioners and physicians.Chronic pancreatitis (CP) is a long-term inflammatory disease of the pancreas, manifested by irreversible morphological changes in the parenchyma and pancreatic ducts, which cause pain and/or persistent impairment of function. Current concept on the etiology of CP is reflected by the TIGAR-O classification. The criteria for establishing the diagnosis of CP include typical attacks of abdominal pain and/or clinical and laboratory signs of exocrine, endocrine insufficiency with the mandatory detection of characteristic morphological changes (calcifications in the parenchyma and pancreatic ductal stones, dilatation of the main pancreatic duct and its branches). CT, MRCP, and pancreatobiliary endosonography are recommended as the methods of choice to verify the diagnosis of CP. Conservative treatment of patients with CP is provided for symptom relief and prevention of complications. Individual cases with severe non-interactable abdominal pain, as well as a complicated course of the disease (development of ductal hypertension due to main pancreatic duct stones or strictures, obstructive jaundice caused by compression of the common bile duct, symptomatic postnecrotic cysts, portal hypertension due to compression of the portal vein or thrombosis of the splenic vein, persistent duodenal obstruction, pseudoaneurysm of the celiac trunk basin and the superior mesenteric artery) serve as an indication for endoscopic or surgical treatment. The Guidelines set out modern approaches to the diagnosis, conservative, endoscopic and surgical treatment of CP, and the prevention of its complications.Conclusion.The implementation of clinical guidelines can contribute to the timely diagnosis and improve the quality of medical care for patients with chronic pancreatitis.
- 15 May 2022
- Published by Russian Gastroenterolgocial Society in Russian Journal of Gastroenterology, Hepatology, Coloproctology
- Vol. 32 (2) , 99-156
Open AccessClinical Guidelines of the Russian Society of Surgeons, the Russian Gastroenterological Association, the Association of Surgeons-Hepatologists and the Endoscopic Society “REndO” on Diagnostics and Treatment of Chronic Pancreatitis
Aim:to present modern methods of diagnosis and treatment of chronic pancreatitis for gastroenterologists, general practitioners and physicians.Chronic pancreatitis (CP) is a long-term inflammatory disease of the pancreas, manifested by irreversible morphological changes in the parenchyma and pancreatic ducts, which cause pain and/or persistent impairment of function. Current concept on the etiology of CP is reflected by the TIGAR-O classification. The criteria for establishing the diagnosis of CP include typical attacks of abdominal pain and/or clinical and laboratory signs of exocrine, endocrine insufficiency with the mandatory detection of characteristic morphological changes (calcifications in the parenchyma and pancreatic ductal stones, dilatation of the main pancreatic duct and its branches). CT, MRCP, and pancreatobiliary endosonography are recommended as the methods of choice to verify the diagnosis of CP. Conservative treatment of patients with CP is provided for symptom relief and prevention of complications. Individual cases with severe non-interactable abdominal pain, as well as a complicated course of the disease (development of ductal hypertension due to main pancreatic duct stones or strictures, obstructive jaundice caused by compression of the common bile duct, symptomatic postnecrotic cysts, portal hypertension due to compression of the portal vein or thrombosis of the splenic vein, persistent duodenal obstruction, pseudoaneurysm of the celiac trunk basin and the superior mesenteric artery) serve as an indication for endoscopic or surgical treatment. The Guidelines set out modern approaches to the diagnosis, conservative, endoscopic and surgical treatment of CP, and the prevention of its complications.Conclusion.The implementation of clinical guidelines can contribute to the timely diagnosis and improve the quality of medical care for patients with chronic pancreatitis.